S. 4350, COVID–19 Medical Debt Collection Relief Act of 2020
Summary
S. 4350, the COVID-19 Medical Debt Collection Relief Act of 2020, was introduced in the Senate on July 29, 2020, by Van Hollen with Murphy. It provides immediate relief for patients from certain medical debt collection efforts during and immediately after the COVID-19 public health emergency. The covered period begins on February 1, 2020. A civil action provision allows damages not to exceed $1,000 for each failure to comply, and in a class action an amount for other class members not to exceed the lesser of $2,000,000 or 1 percent of the annual net income of the covered provider, plus costs and a reasonable attorney's fee.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
- Issuer
- Congressional materials
- Document type
- Bills Bills 116S4350Is Bills 116S4350Is
- Case
- Bills Bills 116S4350Is Bills 116S4350Is
Cite this document
“S. 4350, COVID–19 Medical Debt Collection Relief Act of 2020.”
Original at www.govinfo.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/bills-bills-116s4350is-bills-116s4350is/
, SHA-256 09ae916cd6221708e3ef3ce0913f6c5754f9b73bd51adead5948704a986b0bbf.Full text
II
116TH CONGRESS
2D SESSION
S. 4350
To provide immediate relief for patients from certain medical debt collection
efforts during and immediately after the COVID–19 public health emergency.
IN THE SENATE OF THE UNITED STATES
JULY 29, 2020
Mr. VAN HOLLEN (for himself and Mr. MURPHY) introduced the following bill;
which was read twice and referred to the Committee on Health, Edu-
cation, Labor, and Pensions
A BILL
To provide immediate relief for patients from certain medical
debt collection efforts during and immediately after the
COVID–19 public health emergency.
1 Be it enacted by the Senate and House of Representa-
2 tives of the United States of America in Congress assembled,
3 SECTION 1. SHORT TITLE.
4 This Act may be cited as the ‘‘COVID–19 Medical
5 Debt Collection Relief Act of 2020’’.
6 SEC. 2. RELIEF FROM MEDICAL DEBT COLLECTION.
7 (a) DEFINITIONS.—In this section:
pbinns on DSKJLVW7X2PROD with BILLS
VerDate Sep 11 2014 04:53 Aug 10, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S4350.IS S4350
2
1 (1) COVERED PERIOD.—The term ‘‘covered pe-
2 riod’’ means the period beginning on February 1,
3 2020, and ending on the date that is the later of—
4 (A) the end of the incident period with re-
5 spect to the emergency involving Federal pri-
6 mary responsibility determined to exist by the
7 President under section 501(b) of the Robert T.
8 Stafford Disaster Relief and Emergency Assist-
9 ance Act (42 U.S.C. 5191(b)) with respect to
10 the coronavirus disease 2019 (COVID–19); or
11 (B) 18 months after the date of enactment
12 of this Act.
13 (2) COVERED PROVIDER.—The term ‘‘covered
14 provider’’ means any entity or individual that—
15 (A) provides health care services to pa-
16 tients; and
17 (B) has applied for or accepted any Fed-
18 eral funds for COVID–19 health care costs or
19 financial relief, including funds allocated under
20 the Families First Coronavirus Response Act
21 (Public Law 116–127), the CARES Act (Public
22 Law 116–136), or any other Federal law that
23 allocates COVID–19 relief funding.
24 (3) EXTRAORDINARY COLLECTION ACTIONS.—
pbinns on DSKJLVW7X2PROD with BILLS
25 The term ‘‘extraordinary collection actions’’ means
•S 4350 IS
VerDate Sep 11 2014 04:53 Aug 10, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S4350.IS S4350
3
1 the actions described in section 1.501(r)–6(b) of title
2 26, Code of Federal Regulations.
3 (4) MEDICAL DEBT.—The term ‘‘medical debt’’
4 means a debt arising from the receipt of medical
5 services, products, or devices.
6 (5) SECRETARY.—The term ‘‘Secretary’’ means
7 the Secretary of Health and Human Services.
8 (b) SUSPENSION OF COLLECTION ACTIVITIES.—A
9 covered provider and agents operating on behalf of covered
10 providers shall suspend all extraordinary collection actions
11 relating to the collection of a medical debt relating to a
12 patient during the covered period.
13 (c) SUSPENSION OF REPAYMENT PLANS.—
14 (1) IN GENERAL.—With respect to a patient
15 who has entered into a repayment plan with a cov-
16 ered provider relating to a medical debt, such pro-
17 vider shall suspend such repayment plan upon the
18 request of the patient or the patient’s guardian for
19 the duration of the covered period, and ensure the
20 application of reasonable forbearance and repayment
21 options when such repayments resume. Such options
22 may include maintaining the same payment schedule
23 with respect to the medical debt by extending the re-
24 payment period by the same period of time that pay-
pbinns on DSKJLVW7X2PROD with BILLS
25 ments were suspended under the previous sentence.
•S 4350 IS
VerDate Sep 11 2014 04:53 Aug 10, 2020 Jkt 099200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\S4350.IS S4350
4
1 (2) INTEREST AND FEES.—Interest or fees
2 shall not accrue during the period in which a pay-
3 ment plan is suspended under paragraph (1).
4 (d) APPLICATION OF CERTAIN CONSUMER PROTEC-
5 TIONS.—
6 (1) IN GENERAL.—Medical debt incurred dur-
7 ing the period beginning on February 1, 2020, and
8 ending on the date that is 60 days after the lifting
9 of the state of emergency for COVID–19-related
10 testing and treatment (as determined by the Sec-
11 retary) shall be subject to the following consumer
12 protections:
13 (A) A one-year extension of Federal and
14 State health insurance appeal deadlines, includ-
15 ing the deadlines set forth in section 2719 of
16 the Public Health Service Act (42 U.S.C.
17 300gg–19) and sections 2590.715 through
18 2179 of title 29, Code of Federal Regulations,
19 and the appeal and grievance deadlines for the
20 denials of Medicare or Medicaid claims under
21 titles XVIII and XIX of the Social Security Act
22 (42 U.S.C. 1395 and 1396 et seq.).
23 (B) A prohibition on the accrual and col-
24 lection of fees and interest related to the med-
pbinns on DSKJLVW7X2PROD with BILLS
25 ical debts involved.
•S 4350 IS
VerDate Sep 11 2014 04:53 Aug 10, 2020 Jkt 099200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\S4350.IS S4350
5
1 (C) A prohibition on any extraordinary col-
2 lection actions as described in section 1.501(r)–
3 6(b) of title 26, Code of Federal Regulations.
4 (2) COVID–19-RELATED TESTING AND TREAT-
5 MENT.—For purposes of paragraph (1), the term
6 ‘‘COVID–19-related testing and treatment’’ includes
7 items and services (including in-person or telehealth
8 visits in which such items and services are fur-
9 nished) that are furnished—
10 (A) to an individual who has been diag-
11 nosed with (or after the provision of such items
12 and services is diagnosed with) COVID–19 to
13 treat or mitigate the effects of COVID–19; and
14 (B) to an individual who is presumed by a
15 health care provider to have COVID–19 but is
16 never diagnosed as such.
17 (e) PENALTIES.—Except as provided in this section,
18 a covered provider or its agent that fails to comply with
19 any provision of this section with respect to a patient shall
20 be liable to such patient for damages in an amount equal
21 to the sum of—
22 (1) any actual damages sustained by such pa-
23 tient as a result of such failure to comply;
24 (2) in the case of an action commenced—
pbinns on DSKJLVW7X2PROD with BILLS •S 4350 IS
VerDate Sep 11 2014 04:53 Aug 10, 2020 Jkt 099200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\S4350.IS S4350
6
1 (A) by an individual, any additional dam-
2 ages as the court may permit, but not to exceed
3 $1,000 for each failure to comply; or
4 (B) by a class of patients—
5 (i) such amount for each named plain-
6 tiff as could be recovered under paragraph
7 (1) and subparagraph (A); and
8 (ii) such amount as the court may
9 allow for all other class members, without
10 regard to a minimum individual recovery,
11 not to exceed the lesser of $2,000,000 or
12 1 percent of the annual net income of the
13 covered provider; and
14 (3) in the case of any successful action under
15 this section, the costs of the action, together with a
16 reasonable attorney’s fee as determined appropriate
17 by the court.
Æ
pbinns on DSKJLVW7X2PROD with BILLS •S 4350 IS
VerDate Sep 11 2014 04:53 Aug 10, 2020 Jkt 099200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6301 E:\BILLS\S4350.IS S4350
File and source
- File
- BILLS_bills-116s4350is_bills-116s4350is.pdf
- Size
- 236,039 bytes
- SHA-256
- 09ae916cd6221708e3ef3ce0913f6c5754f9b73bd51adead5948704a986b0bbf
- Original
- www.govinfo.gov